• Concurrent chemoradiotherapy significantly improves overall survival and progression-free survival in locally advanced cervical cancer compared to radiotherapy alone.
• Cisplatin-based regimens and intensity-modulated radiotherapy (IMRT) are associated with better clinical outcomes.
• CCRT increases the risk of grade 3-4 hematologic and gastrointestinal toxicities, which require proactive management.
• These findings support CCRT as the standard of care for LACC, emphasizing the need for individualized treatment planning.
Download Full PDF: Radiotherapy Combined with Concurrent Chemotherapy in the Treatment of Locally Advanced Cervical Cancer: A Systematic Review and Meta-Analysis | SinoBioData | SinoBioData